Cargando…

The health and quality of life of Thalidomide survivors as they age – Evidence from a UK survey

BACKGROUND: In the late 1950s and early 1960s the drug Thalidomide was marketed across the world as a non-addictive tranquilizer. Despite being given to pregnant women as a safe treatment for morning sickness, Thalidomide caused serious damage to the unborn child. Much has been written about the dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Newbronner, Elizabeth, Glendinning, Caroline, Atkin, Karl, Wadman, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334953/
https://www.ncbi.nlm.nih.gov/pubmed/30650111
http://dx.doi.org/10.1371/journal.pone.0210222
_version_ 1783387817085239296
author Newbronner, Elizabeth
Glendinning, Caroline
Atkin, Karl
Wadman, Ruth
author_facet Newbronner, Elizabeth
Glendinning, Caroline
Atkin, Karl
Wadman, Ruth
author_sort Newbronner, Elizabeth
collection PubMed
description BACKGROUND: In the late 1950s and early 1960s the drug Thalidomide was marketed across the world as a non-addictive tranquilizer. Despite being given to pregnant women as a safe treatment for morning sickness, Thalidomide caused serious damage to the unborn child. Much has been written about the drug and the birth defects it caused but evidence about the health of Thalidomide survivors as they age is limited. AIM: The aim of this study was to: explore the health and wellbeing UK Thalidomide survivors; document the health problems experienced by them as they reach their mid-50s; and examine the impacts on their health-related quality of life and employment. METHODS: A health and wellbeing survey of 351 UK Thalidomide survivors, which gathered information about home and employment circumstances, recent health problems, and health related quality of life (using SF12 Health Survey). Overall analysis focused on descriptive statistics; the association between respondents’ health related quality of life and original impairment was examined using Pearson Correlation; and a three step Hierarchical Regression was used to explore the influence of five factors which narrative responses suggested might be important. RESULTS: As Thalidomide survivors reach their mid-50’s they are experiencing a wide range of secondary health problems, in particular musculoskeletal problems, and depression and anxiety, with multimorbidity a growing issue. These health problems are having a negative impact on their employment (two fifths are unable to work) and their physical health related quality of life, which is significantly poorer than the general population. DISCUSSION: Having lived relatively independent lives, many Thalidomide survivors are now having to adjust to growing disability. The study provides further evidence of the accumulative impact of disability over peoples’ lifetimes and highlights the value of a life course perspective in understanding the complex experience of growing older with a disability.
format Online
Article
Text
id pubmed-6334953
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63349532019-01-31 The health and quality of life of Thalidomide survivors as they age – Evidence from a UK survey Newbronner, Elizabeth Glendinning, Caroline Atkin, Karl Wadman, Ruth PLoS One Research Article BACKGROUND: In the late 1950s and early 1960s the drug Thalidomide was marketed across the world as a non-addictive tranquilizer. Despite being given to pregnant women as a safe treatment for morning sickness, Thalidomide caused serious damage to the unborn child. Much has been written about the drug and the birth defects it caused but evidence about the health of Thalidomide survivors as they age is limited. AIM: The aim of this study was to: explore the health and wellbeing UK Thalidomide survivors; document the health problems experienced by them as they reach their mid-50s; and examine the impacts on their health-related quality of life and employment. METHODS: A health and wellbeing survey of 351 UK Thalidomide survivors, which gathered information about home and employment circumstances, recent health problems, and health related quality of life (using SF12 Health Survey). Overall analysis focused on descriptive statistics; the association between respondents’ health related quality of life and original impairment was examined using Pearson Correlation; and a three step Hierarchical Regression was used to explore the influence of five factors which narrative responses suggested might be important. RESULTS: As Thalidomide survivors reach their mid-50’s they are experiencing a wide range of secondary health problems, in particular musculoskeletal problems, and depression and anxiety, with multimorbidity a growing issue. These health problems are having a negative impact on their employment (two fifths are unable to work) and their physical health related quality of life, which is significantly poorer than the general population. DISCUSSION: Having lived relatively independent lives, many Thalidomide survivors are now having to adjust to growing disability. The study provides further evidence of the accumulative impact of disability over peoples’ lifetimes and highlights the value of a life course perspective in understanding the complex experience of growing older with a disability. Public Library of Science 2019-01-16 /pmc/articles/PMC6334953/ /pubmed/30650111 http://dx.doi.org/10.1371/journal.pone.0210222 Text en © 2019 Newbronner et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Newbronner, Elizabeth
Glendinning, Caroline
Atkin, Karl
Wadman, Ruth
The health and quality of life of Thalidomide survivors as they age – Evidence from a UK survey
title The health and quality of life of Thalidomide survivors as they age – Evidence from a UK survey
title_full The health and quality of life of Thalidomide survivors as they age – Evidence from a UK survey
title_fullStr The health and quality of life of Thalidomide survivors as they age – Evidence from a UK survey
title_full_unstemmed The health and quality of life of Thalidomide survivors as they age – Evidence from a UK survey
title_short The health and quality of life of Thalidomide survivors as they age – Evidence from a UK survey
title_sort health and quality of life of thalidomide survivors as they age – evidence from a uk survey
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334953/
https://www.ncbi.nlm.nih.gov/pubmed/30650111
http://dx.doi.org/10.1371/journal.pone.0210222
work_keys_str_mv AT newbronnerelizabeth thehealthandqualityoflifeofthalidomidesurvivorsastheyageevidencefromauksurvey
AT glendinningcaroline thehealthandqualityoflifeofthalidomidesurvivorsastheyageevidencefromauksurvey
AT atkinkarl thehealthandqualityoflifeofthalidomidesurvivorsastheyageevidencefromauksurvey
AT wadmanruth thehealthandqualityoflifeofthalidomidesurvivorsastheyageevidencefromauksurvey
AT newbronnerelizabeth healthandqualityoflifeofthalidomidesurvivorsastheyageevidencefromauksurvey
AT glendinningcaroline healthandqualityoflifeofthalidomidesurvivorsastheyageevidencefromauksurvey
AT atkinkarl healthandqualityoflifeofthalidomidesurvivorsastheyageevidencefromauksurvey
AT wadmanruth healthandqualityoflifeofthalidomidesurvivorsastheyageevidencefromauksurvey